Skip to main content

Table 3 Univariate and multivariate analysis of the effects of different treatment strategies at follow-Up, N (%)

From: Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study

 

No. patients with event

Univariate analysis

Multivariate analysis*

CR

SR

HR (95 % CI)

P

HR (95 % CI)

P

Primary end points

Cardiac mortality/Nonfatal reinfarction

31 (8.1)

8 (3.6)

0.427 (0.196–0.929)

0.032

0.430 (0.197–0.940)

0.034

Secondary end points

Cardiac mortality

17 (4.5)

4 (1.8)

0.400 (0.135–1.190)

0.100

0.440 (0.147–1.319)

0.143

Nonfatal reinfarction

14 (3.7)

4 (1.8)

0.467 (0.153–1.418)

0.179

0.442 (0.143–1.365)

0.156

All-cause mortality

19 (5.0)

5 (2.3)

0.442 (0.165–1.185)

0.105

0.489 (0.181–1.321)

0.158

Unplanned repeat revascularization

42 (11.0)

9 (4.1)

0.349 (0.170–0.717)

0.004

0.343 (0.166–0.708)

0.004

  1. *Adjusted for age, diabetes, hypertension, Killip class II/III on admission, systolic blood pressure on admission, heart rate on admission, symptom to balloon time, and anterior MI